Brawn Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve the audited financial results ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Brawn Biotech Ltd has informed BSE that a meeting of its Board of Directors is scheduled for May 29, 2026 to consider and approve the audited financial results for the quarter and financial year ended March 31, 2026. The company also noted that its trading window remains closed for insiders till May 31, 2026, reopening on June 1, 2026, in line with SEBI's Code of Conduct for regulating insider trading. This is a standard regulatory intimation under SEBI Listing Regulations. No financial figures, audit opinions, or specific agenda items beyond results approval are disclosed in this filing.
This is a routine pre-results announcement. No investment-relevant signals can be derived until the actual audited results are released following the board meeting.